NS Partners Ltd lessened its holdings in Waters Co. (NYSE:WAT) by 0.4% in the 2nd quarter, Holdings Channel.com reports. The fund owned 55,037 shares of the medical instruments supplier’s stock after selling 195 shares during the period. NS Partners Ltd’s holdings in Waters were worth $11,846,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of WAT. MERIAN GLOBAL INVESTORS UK Ltd acquired a new stake in Waters in the first quarter worth about $70,947,000. FMR LLC boosted its holdings in Waters by 88.8% in the first quarter. FMR LLC now owns 382,877 shares of the medical instruments supplier’s stock worth $96,374,000 after acquiring an additional 180,046 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in Waters by 87.6% in the second quarter. Wells Fargo & Company MN now owns 262,522 shares of the medical instruments supplier’s stock worth $56,506,000 after acquiring an additional 122,579 shares in the last quarter. AJO LP boosted its holdings in Waters by 188.7% in the first quarter. AJO LP now owns 186,568 shares of the medical instruments supplier’s stock worth $46,961,000 after acquiring an additional 121,953 shares in the last quarter. Finally, First Trust Advisors LP boosted its holdings in Waters by 1,148.3% in the second quarter. First Trust Advisors LP now owns 86,505 shares of the medical instruments supplier’s stock worth $18,619,000 after acquiring an additional 79,575 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.
Shares of Waters stock traded up $0.87 on Tuesday, reaching $203.92. 11,225 shares of the stock were exchanged, compared to its average volume of 565,381. The company has a quick ratio of 2.07, a current ratio of 2.65 and a debt-to-equity ratio of 2.00. Waters Co. has a twelve month low of $167.93 and a twelve month high of $255.21. The firm has a market capitalization of $13.67 billion, a price-to-earnings ratio of 24.61, a PEG ratio of 2.30 and a beta of 1.07. The business has a 50 day moving average price of $211.96 and a two-hundred day moving average price of $222.87.
WAT has been the subject of several recent analyst reports. Wolfe Research initiated coverage on Waters in a report on Thursday, May 30th. They issued an “underperform” rating for the company. Cleveland Research downgraded Waters from a “neutral” rating to an “underperform” rating in a report on Wednesday, June 12th. Zacks Investment Research raised Waters from a “sell” rating to a “hold” rating and set a $217.00 price target for the company in a report on Wednesday, May 22nd. Bank of America downgraded Waters from a “neutral” rating to an “underperform” rating in a report on Tuesday, July 16th. Finally, ValuEngine downgraded Waters from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Five research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $210.54.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Article: Key terms to understand channel trading
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.